@IUjvary 3) As for pharmakinetic/dynamic of microdosing, this is the only paper I am aware of: https://t.co/PzshmY5PHk 4) and finally this one is on receptor occupancy/plasma levels in the 'microdose dose regime': https://t.co/E9paANAjn8. Hope these help!
@steuben_baron @DrMcFillin Yes. Safety studies have already succeeded. https://t.co/ECUE9y1a3N It was so safe, that the placebo group had more adverse events. 🤦♂️ 86 year old dimentia patients also have limited capacity to turn homicidalon SSRIs. https:
@GrahamM37311706 @ETagliazucchi Well it didn't work for old people who typically have somewhat worse performance on most cognitive tasks: https://t.co/tBtXDgYrds
@ETagliazucchi B/c the story is “microdosing does little if anything,” I’d say it should be 1 paper (see https://t.co/wMtLvAcoht, @neiloufar cleverly framed it as “no impairment” 😜). If you’d found interesting effects in 1 or 2 of mood, creativity, or atte
RT @ViewsOnDrugsBot: Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy o…
RT @ViewsOnDrugsBot: Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy o…
RT @dreamgbutterfly: Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy o…
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers 1/5 https://t.co/1DtfYyARKI
@RebeccaMadison_ 8/ both correlation data (https://t.co/p0GHsSOsKo) and our understanding of the mechanism (5-HT2B inhibitor) is compelling enough (https://t.co/bhRuslIvRQ) for most experts in the field to conclude this is a real danger (https://t.co/lEoxt
@Gemmasparkle @ambiguustom @BarnsGreg @vincepsy @ConversationEDU Can you provide any peer-reviewed literature showing 10ug of LSD leads to *any* of these symptoms? Maybe *you* should review the literature before you start firing up on SM 😇 https://t.co/23b
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers https://t.co/tnqYHpXFyt https://t.co/ExIPVcqlEj
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers https://t.co/S2RLIQUdwe
RT @Entheogenist: https://t.co/EIZbrWs8ZA Psychedelics and neurodegenerative diseases
@CoticSi @geraldgoincrazy @D_Maksa @5e4nW4rd @Connorlivingsto @highimhayley @machinegunkelly https://t.co/0MRof37ZWR https://t.co/LL33JtXHrQ https://t.co/nxZVhyTEjl https://t.co/nZe5qqW7zv good reading guys just so you know 5ht is serotonin
"Conclusions: Our results suggest safety and tolerability of orally administered ... LSD every fourth day over a 21-day period and support further clinical development of LSD for the treatment and prevention of Alzheimer's disease (AD)." https://t.co/XUoLx
RT @Greenthumb_one: Full-text pdf: https://t.co/B17GjJIPDu https://t.co/4CvTqKX8Lb
Full-text pdf: https://t.co/B17GjJIPDu https://t.co/4CvTqKX8Lb
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. https://t.co/ttJTlRoAsh
@thirdwaveishere @ReillyCapps In older adults, Family et al., found: "LSD was well tolerated, and the frequency of adverse events was no higher than for placebo. Assessments of cognition, balance, and proprioception revealed no impairment." ... https://t.c
@RichardShama @RCarhartHarris There's research on that, too. This study gave low doses of LSD to healthy older adults to test tolerability, with an eye towards future Alzheimer's research. The LSD didn't do a whole lot, one way or another, but it was a sm
https://t.co/EIZbrWs8ZA Psychedelics and neurodegenerative diseases
@PaulAustin3w Also, this study of low-dose LSD on older adults. The key results: "LSD was well tolerated, and the frequency of adverse events was no higher than for placebo. Assessments of cognition, balance, and proprioception revealed no impairment." ht
“Our results suggest safety and tolerability of orally administered 5 μg, 10 μg, and 20 μg LSD every fourth day over a 21-day period and support further clinical development of LSD for the treatment and prevention of Alzheimer’s disease (AD).” https://t.co
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers https://t.co/B98tSDGeiJ #psychedelics #LSD #microdosing #elders #eldercare #safety #research #science
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @grawoig: Article: https://t.co/1qgxbwlIWM (OPEN) "Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic aci…
https://t.co/C8Lf6EBMAk My future suddenly starts to look better (Hallucination pun intended).
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
@ReillyCapps @OpenMindHC Thanks, though this is the proper source. Getting the facts straight from the authors is better than a layperson’s attempt to interpret it. https://t.co/NGWNCqoIFX
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
Very interesting
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @AlexWodak: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. How good is that? Sorry. Wrong re…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @ichiipsy: LSDを使ったうつ病やアルツハイマー型認知症への治療が安全であると、高齢者を対象にした臨床実験によって示唆されました。今後はアルツハイマー型認知症の治療と予防に向けてさらなる研究がなされるようです。幻覚剤を使用した治療の安全性への議論は尽きません。…
RT @ichiipsy: LSDを使ったうつ病やアルツハイマー型認知症への治療が安全であると、高齢者を対象にした臨床実験によって示唆されました。今後はアルツハイマー型認知症の治療と予防に向けてさらなる研究がなされるようです。幻覚剤を使用した治療の安全性への議論は尽きません。…
RT @ichiipsy: LSDを使ったうつ病やアルツハイマー型認知症への治療が安全であると、高齢者を対象にした臨床実験によって示唆されました。今後はアルツハイマー型認知症の治療と予防に向けてさらなる研究がなされるようです。幻覚剤を使用した治療の安全性への議論は尽きません。…
RT @ichiipsy: LSDを使ったうつ病やアルツハイマー型認知症への治療が安全であると、高齢者を対象にした臨床実験によって示唆されました。今後はアルツハイマー型認知症の治療と予防に向けてさらなる研究がなされるようです。幻覚剤を使用した治療の安全性への議論は尽きません。…
LSDを使ったうつ病やアルツハイマー型認知症への治療が安全であると、高齢者を対象にした臨床実験によって示唆されました。今後はアルツハイマー型認知症の治療と予防に向けてさらなる研究がなされるようです。幻覚剤を使用した治療の安全性への議論は尽きません。 https://t.co/eHVJi31U5n
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @AlexWodak: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. How good is that? Sorry. Wrong re…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
#LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. How good is that? Sorry. Wrong response. Yes but will this normalise LSD among old people leading to Gateway tsunami? What kind of message is being sent? #microd
RT @stephenjbright: BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might b…
BREAKING NEWS: #LSD found to be safe & tolerated by 48 older adults in pre-clinical trial of #Alzheimers. There might be another be benefit of #microdosing #psychedelic #drugs! https://t.co/Up2w9Mgbu4
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers | SpringerLink https://t.co/OBOY27KTKn
RT @MendelKaelen: "The only minor clinical difference between placebo and active treatment groups was the number of headaches reported." 🤔…
"The only minor clinical difference between placebo and active treatment groups was the number of headaches reported." 🤔 https://t.co/1V3g3zvt1P
RT @jameswjesso: Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose(#microdosing) lysergic acid diethylamide (#LSD) i…
RT @grawoig: Article: https://t.co/1qgxbwlIWM (OPEN) "Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic aci…
Article: https://t.co/1qgxbwlIWM (OPEN) "Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers" by Neiloufar Family, Emeline L. Maillet, Luke T. J. Williams, Erwin Krediet, &am
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers https://t.co/xlUSQ9nw6E
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose(#microdosing) lysergic acid diethylamide (#LSD) in healthy older volunteers https://t.co/UUpmERMftC
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers - https://t.co/SytlhfNVKi
Wissenschaftler erforschen, ob geringe Dosen von LSD, die man psychisch nicht bemerkt, gegen Alzheimer helfen https://t.co/sXXviGWnbG https://t.co/t4EH6EOETh
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. https://t.co/ttJTlRoAsh
Research has shown that psychedelics, such as LSD have profound anti-inflammatory properties. A new phase 1 double- https://t.co/uRnq6E4jQj
RT @ManojDoss: Once again, microdosing not found to enhance cognition on multiple tasks in a population that may have especially benefited…
https://t.co/EBWMxifc9f Research has shown that psychedelics, such as LSD have profound anti-inflammatory properties. A new phase 1 double-blind, placebo-controlled, randomized study suggests safety of microdosing LSD and support further clinical developme
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
"Our results suggest safety and tolerability of orally administered 5 μg, 10 μg, and 20 μg LSD every fourth day over a 21-day period and support further clinical development of LSD for the treatment and prevention of Alzheimer’s disease (AD)." https://t.co
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
RT @BellevueDoc: interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co…
interesting study on microdosing LSD in older population. showing it's safe and well-tolerated, for starters. https://t.co/wVO6BayJMk
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
I guess we were wrong that time dilation under microdoses of LSD may have resulted from attentional and working memory impairment.. The awaited microdosinf safety paper is finally out https://t.co/g7Jq31cMrb Well done Eleusis. #microdosing #LSD #psychedeli
Important point from new LSD microdosing clinical study: People who got placebo reported as many or more psychiatric/nervous-system effects (like mood changes, sleep issues, visual illusions). https://t.co/YqD098yraH
Scientists prepare to study LSD microdoses for prevention/treatment of Alzheimer's! First step: trial of 20mcg in healthy older adults, "administration of low dose LSD carried no safety risk and was well tolerated".
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @neiloufar: Happy to announce the publication of our phase 1 results of low dose LSD in older healthy adults. @EleusisLtd https://t.co/F…
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @mattbagg: Essentially no effects detected from giving up to 20ug LSD every 4 days for 6 total doses to older volunteers. https://t.co/d…
Essentially no effects detected from giving up to 20ug LSD every 4 days for 6 total doses to older volunteers. https://t.co/dfuD4xnNIq